ANDREW KOPEL, MD
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1568575140
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,036 | 25,830 | $5,546,499 | $1,564,583 | $1,203,308 |
| 2023 | 967 | 15,220 | $6,820,904 | $1,514,336 | $1,166,267 |
| 2022 | 926 | 6,155 | $6,793,656 | $1,374,658 | $1,061,413 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 18,900 | $35 | $27 |
| 92014 | Established patient complete exam of visual system | 2,224 | $127 | $89 |
| 92134 | Imaging of retina | 2,142 | $41 | $30 |
| 67028 | Injection of drug into eye | 538 | $115 | $85 |
| J0177 | Injection, aflibercept hd, 1 mg | 504 | $331 | $264 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 284 | $25 | $18 |
| 92250 | Photography of the retina | 237 | $38 | $28 |
| J0178 | Injection, aflibercept, 1 mg | 236 | $836 | $662 |
| 92012 | Established patient problem focused exam of visual system | 120 | $90 | $68 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 57 | $173 | $108 |
| 92083 | Exam of visual field with extended testing | 51 | $65 | $49 |
| 92133 | Imaging of optic nerve | 48 | $35 | $25 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | M3618 | TX |
| Ophthalmology Physician | 207W00000X | M3618 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.